Ashley studied Biostatistics at State University of New York at Albany. She finished her PhD in the statistical area of non-likelihood-based model evaluation in 2013. Afterwards she completed a post-doctoral program at Weill Cornell Medical College in the School of Epidemiology and Biostatistics. Currently, she is leading a team of statisticians at Regeneron Pharmaceuticals, Inc. supporting all aspects of drug manufacturing. Ashley joined the IABS Scientific Organizing Committee in 2022.